RREB1 (Ras-responsive element binding protein 1) functions as a transcriptional effector that links RAS and TGF-β signaling pathways to regulate diverse cellular processes including epithelial-mesenchymal transition (EMT), fibrosis, and cancer progression 1. The protein binds to RAS-responsive elements in gene promoters and acts as both a transcriptional activator and repressor depending on context 1. RREB1 coordinates with TGF-β-activated SMAD factors to induce developmental and fibrogenic EMTs by directly activating SNAIL expression and fibrogenic programs 1. In cancer contexts, RREB1 promotes tumor progression through multiple mechanisms: it enhances metastasis by priming enhancers for TGF-β activation 2, drives renal fibrosis through HRAS palmitoylation and MEK/ERK activation 3, and serves as a translational regulator of nuclear-encoded mitochondrial proteins in acute myeloid leukemia 4. Clinical significance includes recurrent somatic mutations in pancreatic ductal adenocarcinoma 5 and associations with type 2 diabetes risk, with protective alleles linked to smaller adipocytes and improved insulin sensitivity 6. RREB1 represents a critical node integrating RAS and TGF-β signaling with broad implications for development, fibrosis, and cancer therapeutics.